Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Year 2006

The summary for the Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Year 2006 grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Year 2006: The Organ Systems Branch of the Office of Centers, Training, and Resources, Office of the Director, National Cancer Institute invites grant applications for Specialized Programs of Research Excellence (SPOREs) in organ-specific cancers. Applicant institutions are to demonstrate their ability to conduct translational research in the prevention, etiology, screening, diagnosis, and treatment of lymphomas and breast, gastrointestinal (GI), brain, head and neck, and prostate cancers. Translational research, as defined by the Program, uses knowledge of human biology to develop and test the feasibility of cancer-relevant interventions in humans and/or determines the biological basis for observations made in individuals with cancer or in populations at risk for cancer. The support for SPOREs is through an NIH specialized center grant (P50) mechanism. Required components of a SPORE (P50) grant application and grant include: a minimum of four translational research projects, cores, and developmental research and career development programs. A required core in a SPORE is a human cancer tissue core for the particular organ site that will benefit translational research. SPOREs foster extended collaborations in critical areas of research among laboratory and clinical or applied scientists. SPOREs are expected to have a robust research base in the respective cancer, good access to patient populations, and substantial commitment from their institution. Inter-SPORE collaborations and collaborations between SPOREs and other NIH programs are strongly encouraged. Each SPORE and the "network" of SPOREs are expected to conduct research that will have the most immediate impact possible on reducing incidence and mortality of human cancer. Eligible organizations include: for-profit or non-profit domestic organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State government(s); units of local government(s); units of State Tribal government(s); units of local Tribal government(s); eligible agencies of the Federal government; and faith-based or community-based organizations. Foreign institutions are not eligible to apply for P50 SPORE grants. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. The applicants will follow the instructions for the PHS 398 form (available at http://grants.nih.gov/grants/funding/phs398/phs398.html), the current Program Announcement (PA), and SPORE Guidelines (http://spores.nci.nih.gov/). Because of the size and complexity of a SPORE, prospective applicants are urged to consult with the staff of the Organ Systems Branch early in the preparation of the application (see Section VII. Agency Contacts). Special instructions are needed for preparing a SPORE application and are available from the program contact listed under Section VII. Agency Contacts, or at http://spores.nci.nih.gov/. Each applicant (i.e., Principal Investigator) may only submit one application in connection with this program announcement. This PA addresses only SPORE applications for organ sites specified to be received in the year 2006. For further assistance, contact GrantsInfo, Telephone: (301) 435-0714; Email: GrantsInfo@nih.gov. Telecommunications for the hearing impaired is available at: TTY 301-451-0088.
Federal Grant Title: Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Year 2006
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-05-156
Type of Funding: Grant
CFDA Numbers: 93.12193.397
CFDA Descriptions: Oral Diseases and Disorders Research 93.397 Cancer Centers Support Grants
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Aug 18, 2005
Creation Date: Aug 18, 2005
Archive Date: Oct 31, 2006
Total Program Funding:
Maximum Federal Grant Award: $2,500,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are not eligible to apply. Eligible institutions may include foreign components as full research projects, or cores, or as part of a research project or core. SPOREs may also use developmental funds to establish collaborative research efforts with foreign entities. Consortia agreements with foreign institutions must include provisions that ensure adequate representation of women, minorities, and children in all research components that involve clinical trials or any other type of human intervention and must be in compliance with NIH policies.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
More Grants from the National Institutes of Health
Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed)
Summer Research Education Experience Program (Clinical Trials Not Allowed R25)
Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/...
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinica...
The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Lab...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com